C08L101/005

High capacity perchlorate-selective resins from hyperbranched macromolecules

A resin is provided for selectively binding to perchloride and related anions (e.g., TcO.sub.4.sup.−, ReO.sub.4.sup.− and I.sup.−) in aqueous solution. The resin may take the form of microparticles or beads. The beads are prepared by cross-linking macromolecules such as hyperbranched PEI, and quaternizing the amines with hydrocarbon substituents.

Use of a branched polyester

The invention relates to the use of a branched polyester having an average of at least 2.8 terminal groups as additive for a curable pre-polymer composition, wherein the branched polyester acts as de-foaming agent.

Use of a branched polyester

The invention relates to the use of a branched polyester having an average of at least 2.8 terminal groups as additive for a curable pre-polymer composition, wherein the branched polyester acts as de-foaming agent.

SLA RESINS AND METHODS OF MAKING AND USING THE SAME

The present disclosure is directed towards resin compositions and methods of making and using the same, where the resulting resins (e.g. SLA resins) can be utilized in conjunction with additive manufacturing.

SLA RESINS AND METHODS OF MAKING AND USING THE SAME

The present disclosure is directed towards resin compositions and methods of making and using the same, where the resulting resins (e.g. SLA resins) can be utilized in conjunction with additive manufacturing.

Immobilised biological entities

There is described inter alia a device having a surface comprising a layered coating wherein the outer coating layer comprises a plurality of cationic hyperbranched polymer molecules characterized by having (i) a core moiety of molecular weight 14-1,000 Da (ii) a total molecular weight of 1,500 to 1,000,000 Da (iii) a ratio of total molecular weight to core moiety molecular weight of at least 80:1 and (iv) functional end groups, whereby one or more of said functional end groups have an anti-coagulant entity covalently attached thereto.

Immobilised biological entities

There is described inter alia a device having a surface comprising a layered coating wherein the outer coating layer comprises a plurality of cationic hyperbranched polymer molecules characterized by having (i) a core moiety of molecular weight 14-1,000 Da (ii) a total molecular weight of 1,500 to 1,000,000 Da (iii) a ratio of total molecular weight to core moiety molecular weight of at least 80:1 and (iv) functional end groups, whereby one or more of said functional end groups have an anti-coagulant entity covalently attached thereto.

Catalytic cracking process and catalyst system therefor

A catalytic cracking process includes a step of contacting a cracking feedstock with a catalytic cracking catalyst in the presence of a radical initiator for reaction under catalytic cracking conditions. The radical initiator contains a dendritic polymer and/or a hyperbranched polymer. The dendritic polymer and the hyperbranched polymer each independently has a degree of branching of about 0.3-1, and each independently has a weight average molecular weight of greater than about 1000. The catalytic cracking process is beneficial to enhancing and accelerating the free radical cracking of petroleum hydrocarbon and promoting the regulation of cracking activity and product distribution; by using the process disclosed herein, the conversion of catalytic cracking can be improved, the yields of ethylene and propylene can be increased, and the yield of coke can be reduced.

Floor Panel and Method of Manufacturing a Floor Panel

A panel suitable for constructing a floor or wall covering includes a core comprising a mineral composite comprising a mineral and a filler. The panel further comprises an additive within the core in order to improve the flexibility and/or tensile strength of the panel.

OPHTHALMIC DEVICES

An ophthalmic device which is a polymerization product of a monomeric mixture includes (a) one or more cationic initiators comprising one or more polymerizable groups; and (b) one or more alkyl-substituted oxazolines.